Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Methotrexate by Aldeyra Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Methotrexate is under clinical development by Aldeyra Therapeutics and currently in Phase II for Retinitis Pigmentosa (Retinitis). According to GlobalData,...
Methotrexate by Pharmaceutical and Cosmetic Solutions for Rheumatoid Arthritis: Likelihood of Approval
Methotrexate is under clinical development by Pharmaceutical and Cosmetic Solutions and currently in Phase I for Rheumatoid Arthritis. According to...
Risk adjusted net present value: What is the current valuation of Aldeyra Therapeutics's Methotrexate?
Methotrexate is a small molecule commercialized by Aldeyra Therapeutics, with a leading Phase III program in Proliferative Vitreoretinopathy (PVR). According...